Oragenics Balance Sheet Health
Financial Health criteria checks 5/6
Oragenics has a total shareholder equity of $13.0M and total debt of $267.6K, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are $14.8M and $1.7M respectively.
Key information
2.1%
Debt to equity ratio
US$267.64k
Debt
Interest coverage ratio | n/a |
Cash | US$11.43m |
Equity | US$13.01m |
Total liabilities | US$1.75m |
Total assets | US$14.76m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: UAV's short term assets ($14.3M) exceed its short term liabilities ($1.6M).
Long Term Liabilities: UAV's short term assets ($14.3M) exceed its long term liabilities ($152.4K).
Debt to Equity History and Analysis
Debt Level: UAV has more cash than its total debt.
Reducing Debt: UAV's debt to equity ratio has increased from 1.3% to 2.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: UAV has sufficient cash runway for 9 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: UAV is forecast to have sufficient cash runway for 8 months based on free cash flow estimates, but has since raised additional capital.